Sio Capital Management’s Biogen BIIB Stock Holding History

Sio Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-35,900	Closed	-$7.32M	–	52
2022 Q2	$7.32M	Buy	+35,900	New	+$7.34M	2.75%	12
2020 Q3	–	Sell	-13,800	Closed	-$3.69M	–	90
2020 Q2	$3.69M	Sell	13,800 -28,138	-67%	-$8.46M	1.08%	36
2020 Q1	$13.3M	Buy	+41,938	New	+$12.7M	4.45%	6
2019 Q2	–	Sell	-78,596	Closed	-$18.6M	–	72
2019 Q1	$18.6M	Buy	+78,596	New	+$24.7M	5.02%	2
2018 Q4	–	Sell	-19,300	Closed	-$6.82M	–	73
2018 Q3	$6.82M	Buy	+19,300	New	+$6.64M	2.34%	13
2018 Q2	–	Sell	-31,900	Closed	-$8.73M	–	50
2018 Q1	$8.73M	Buy	+31,900	New	+$9.9M	5.25%	5
2017 Q4	–	Sell	-15,549	Closed	-$4.87M	–	52
2017 Q3	$4.87M	Buy	+15,549	New	+$4.6M	2.53%	11
2017 Q2	–	Sell	-27,650	Closed	-$7.56M	–	60
2017 Q1	$7.56M	Buy	+27,650	New	+$7.82M	4.23%	6
2016 Q3	–	Sell	-61,000	Closed	-$14.8M	–	36
2016 Q2	$14.8M	Buy	+61,000	New	+$16.1M	7.54%	2

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Sio Capital Management's BIIB Position: Q3 2022 in Review

Sio Capital Management sold out of Biogen (BIIB) in Q3 2022, closing a stake of 35,900 shares — an estimated $7.32M sold.

Sio Capital Management first reported a position in BIIB in Q2 2016 and held it in 9 quarters. The position peaked at $18.6M in Q1 2019. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

Sio Capital Management reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
Sio Capital Management sold 35,900 Biogen shares in Q3 2022, an estimated $7.32M.
Sio Capital Management first reported a position in Biogen in Q2 2016 and held it in 9 quarters.
Sio Capital Management's Biogen position peaked at $18.6M in Q1 2019.
985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Sio Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.